Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for XOMA in a research report issued on Tuesday, ...

Leerink Partnrs raised their FY2025 earnings estimates for shares of XOMA in a report issued on Tuesday, March 18th. Leerink ...

Trinity Biotech has received earlier than expected ... in 2025 through Trinity Biotech’s New York-based Immco reference l ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Future Origins, a U.S.-based joint venture that is commercializing sustainable alternatives to critical ingredients in the ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for ...

A Florida-based biotech found a tremendous amount of success on Wednesday after it was announced that its non-hallucinogenic psychedelic compounds showed promise for treating addiction and ADHD ...

In addition to green energy companies who streamed through ChinaSF, real estate companies were also involved, and the book ...

A California-based biotech company is finding a tremendous amount of success on Tuesday after the company announced that Eli Lilly is set to acquire its FXR program including FXR314. Traders ...

Lenz will continue to have an advisory role at the company, the biotech said. Last month, CEO Henry Gosebruch left the company to be replaced by co-founder and executive board chair Paul Berns.